Drug Shortage Report for SANDOZ TRANDOLAPRIL
| Report ID | 127782 |
| Drug Identification Number | 02325764 |
| Brand name | SANDOZ TRANDOLAPRIL |
| Common or Proper name | SANDOZ TRANSOLAPRIL |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | TRANDOLAPRIL |
| Strength(s) | 4MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100HGC BO CA |
| ATC code | C09AA |
| ATC description | ACE INHIBITORS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-10-30 |
| Estimated end date | |
| Actual end date | 2020-11-27 |
| Shortage status | Resolved |
| Updated date | 2020-11-28 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.